T&R Biofab Statistics

Total Valuation

T&R Biofab has a market cap or net worth of KRW 102.13 billion. The enterprise value is 121.16 billion.

Market Cap	102.13B
Enterprise Value	121.16B

Important Dates

The next estimated earnings date is Monday, March 17, 2025.

Earnings Date	Mar 17, 2025
Ex-Dividend Date	n/a

Share Statistics

T&R Biofab has 21.55 million shares outstanding. The number of shares has increased by 2.75% in one year.

Current Share Class	n/a
Shares Outstanding	21.55M
Shares Change (YoY)	+2.75%
Shares Change (QoQ)	-0.73%
Owned by Insiders (%)	26.39%
Owned by Institutions (%)	16.72%
Float	15.86M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	20.02
PB Ratio	5.56
P/TBV Ratio	5.86
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-8.82
EV / Sales	23.85
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.96

Financial Position

The company has a current ratio of 0.92, with a Debt / Equity ratio of 1.84.

Current Ratio	0.92
Quick Ratio	0.64
Debt / Equity	1.84
Debt / EBITDA	n/a
Debt / FCF	-2.90
Interest Coverage	-5,908.95

Financial Efficiency

Return on equity (ROE) is -56.70% and return on invested capital (ROIC) is -13.83%.

Return on Equity (ROE)	-56.70%
Return on Assets (ROA)	-10.37%
Return on Capital (ROIC)	-13.83%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.06
Inventory Turnover	1.12

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -41.44% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-41.44%
50-Day Moving Average	6,219.00
200-Day Moving Average	6,825.40
Relative Strength Index (RSI)	28.05
Average Volume (20 Days)	43,564

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, T&R Biofab had revenue of KRW 5.08 billion and -13.74 billion in losses. Loss per share was -640.20.

Revenue	5.08B
Gross Profit	1.42B
Operating Income	-14.73B
Pretax Income	-13.74B
Net Income	-13.74B
EBITDA	-12.21B
EBIT	-14.73B
Loss Per Share	-640.20

Full Income Statement

Balance Sheet

The company has 23.23 billion in cash and 39.26 billion in debt, giving a net cash position of -16.03 billion or -743.92 per share.

Cash & Cash Equivalents	23.23B
Total Debt	39.26B
Net Cash	-16.03B
Net Cash Per Share	-743.92
Equity (Book Value)	21.36B
Book Value Per Share	851.92
Working Capital	-3.02B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.33 billion and capital expenditures -3.20 billion, giving a free cash flow of -13.53 billion.

Operating Cash Flow	-10.33B
Capital Expenditures	-3.20B
Free Cash Flow	-13.53B
FCF Per Share	-627.74

Full Cash Flow Statement

Margins

Gross margin is 27.95%, with operating and profit margins of -289.82% and -270.43%.

Gross Margin	27.95%
Operating Margin	-289.82%
Pretax Margin	-270.43%
Profit Margin	-270.43%
EBITDA Margin	-240.31%
EBIT Margin	-289.82%
FCF Margin	n/a

Dividends & Yields

T&R Biofab does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.75%
Shareholder Yield	-2.75%
Earnings Yield	-13.51%
FCF Yield	-13.24%

Stock Splits

The last stock split was on April 5, 2022. It was a forward split with a ratio of 2.

Last Split Date	Apr 5, 2022
Split Type	Forward
Split Ratio	2

Scores

T&R Biofab has an Altman Z-Score of -1.44. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.44
Piotroski F-Score	n/a